Search

everythinglearnresearchcommunity

for

Search:↓

Most patients who had scalp skin removed for burns as children had normal hair growth and were satisfied years later.

Targeted cancer therapies often cause serious skin problems that need careful management.

Cetuximab can cause eyelash growth, which is rare but manageable.

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.

Body hair transplants can treat baldness but differ from scalp hair and need more research on long-term results and side effects.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Chemotherapy often causes patterned hair loss, with some scalp areas more resistant to hair loss than others.

Cyclosporine A helps hair grow by blocking a process that would otherwise cause hair cells to die.

DCPA is a chronic skin condition affecting the legs, often misdiagnosed, and needs more research for better understanding and treatment.

Cryptococcus gattii can remain dormant in animals for over 8 years.

The combination therapy effectively improved acne keloidalis nuchae.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

Stopping the use of fluocinolone oil containing balsam fragrance improved hair regrowth in children allergic to it.

Cosmeceuticals are important for managing skin issues during the COVID-19 pandemic.

HIV can cause skin disorders, which are often the first sign of infection, especially in people with darker skin.

Primary idiopathic pseudopelade of Brocq causes gradual, scarring hair loss with no effective treatment.

Temporary hair loss can occur after 5-fluorouracil treatment for keloids.

These skin conditions in African men need combined medical treatments and lifestyle changes.

This type of hair loss is probably often missed and treatments reducing inflammation might work well.

Folliculitis Decalvans and Frontal Fibrosing Alopecia can coexist in people with darker skin, showing features of both conditions.

Most patients improved with oral antibiotics, but some needed long-term treatment or had minimal response.

A woman developed folliculitis after taking acitretin for psoriasis, which was treated with skin dressing and antibiotics.

Clindamycin and rifampicin are the most effective treatments for folliculitis decalvans, but more research is needed.

Early onset and pustules indicate severe hair follicle inflammation, and while antibiotics help, the condition often worsens after treatment stops.

Early detection and treatment of folliculitis keloidalis can prevent disease progression.

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

A new surgical method using special sutures significantly reduced wound size and prevented disease return in patients with a scarring scalp condition.

A man developed recurring scalp inflammation and hair loss after a head injury.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

A man developed a rare scalp disorder, Folliculitis Decalvans, 20 years after hair restoration surgery, and it required long-term antibiotic treatment.